Table 2

Frequency and distribution of individual nucleotide mutations

X-HIgM
Normal donors
NPPNPP
RGYW (%) 8.5/51 (17) 56.5/250 (23)* 147/593 (25)* 1227.3/4857 (25)* 
WRCY (%) 9.5/51 (19) 31.5/250 (13) 84/593 (14) 697.5/4857 (14) 
WA (%) 8/51 (16) 54/250 (22) 137.4/5933 (23) 890.5/4857 (18) 
TW 6/51 (12) 22/250 (9) 66.7/593 (11) 488.5/4857 (10) 
FR (R/S) 21/12 (1.8) 114/50 (2.3) 304/92 (3.3)§ 1961/1155 (1.7) 
CDR (R/S) 14/4 (3.5) 68/20 (3.4) 166/29 (5.7) 1347/394 (3.4) 
Transitions (%) 33/51 (65) 140/250 (56) 302/593 (51) 2626/4857 (54) 
Transversions (%) 18/51 (35) 110/250 (44) 291/593 (49) 2231/4857 (46) 
X-HIgM
Normal donors
NPPNPP
RGYW (%) 8.5/51 (17) 56.5/250 (23)* 147/593 (25)* 1227.3/4857 (25)* 
WRCY (%) 9.5/51 (19) 31.5/250 (13) 84/593 (14) 697.5/4857 (14) 
WA (%) 8/51 (16) 54/250 (22) 137.4/5933 (23) 890.5/4857 (18) 
TW 6/51 (12) 22/250 (9) 66.7/593 (11) 488.5/4857 (10) 
FR (R/S) 21/12 (1.8) 114/50 (2.3) 304/92 (3.3)§ 1961/1155 (1.7) 
CDR (R/S) 14/4 (3.5) 68/20 (3.4) 166/29 (5.7) 1347/394 (3.4) 
Transitions (%) 33/51 (65) 140/250 (56) 302/593 (51) 2626/4857 (54) 
Transversions (%) 18/51 (35) 110/250 (44) 291/593 (49) 2231/4857 (46) 

The X-HIgM data include 104 productive (P) and 24 nonproductive (NP) CD19+IgD+ and CD19+CD27+ mutated rearrangements. Normal donor populations include 483 P and 69 NP CD19+IgM+, IgD+CD27+, and IgDCD27+ mutated rearrangements.

FR indicates framework region; CDR, complementarity determining region; R/S indicates replacement-to-silent mutation ratio. All positions of the motif were included for mutation analysis. AGCT motifs with a mutated G but not C were considered RGYW motif mutations. AGCT motifs with a mutated C but not G were considered WRCY motif mutations. Three ambiguous A or T mutations in AGCT motifs with neither G or C mutations were scored as a mutation in RGYW and WRCY motifs.

*

Significant (P < .05) difference between RGYW and WRCY mutations.

Significant (P = .03) difference between X-HIgM and normal donors nonproductive rearrangements.

Significantly (P = .05) greater mutation frequency compared with the expected random frequency.

§

Significant (P < .05) difference between the NP and P FR R/S of ND.

Significant (P = .02) difference between the NP FR R:S and NP CDR R:S of ND.

Significant (P = .03) difference between the percentage of transitions versus transversions.

or Create an Account

Close Modal
Close Modal